These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36357462)

  • 41. Magnetically Coated Bioabsorbable Stents for Renormalization of Arterial Vessel Walls after Stent Implantation.
    Lee JS; Han P; Song E; Kim D; Lee H; Labowsky M; Taavitsainen J; Ylä-Herttuala S; Hytönen J; Gülcher M; Perampaladas K; Sinusas AJ; Martin J; Mathur A; Fahmy TM
    Nano Lett; 2018 Jan; 18(1):272-281. PubMed ID: 29268605
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Everolimus-eluting stent for the treatment of bare metal in-stent restenosis: clinical and angiographic outcomes at nine-month follow-up of XERES (Xience Evaluation in bare metal stent REStenosis) trial.
    Carrié D; Delarche N; Piot C; Berland J; Menneveau N; Bonello L; Py A; Teiger E; Leborgne L; Bayet G; Wittenberg O; Schiele F
    EuroIntervention; 2014 Oct; 10(6):700-8. PubMed ID: 24334825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel intravascular drug delivery method using endothelial biotinylation and avidin-biotin binding.
    Hoya K; Guterman LR; Miskolczi L; Hopkins LN
    Drug Deliv; 2001; 8(4):215-22. PubMed ID: 11757779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-stent restenosis in bare metal stents versus sirolimus-eluting stents after primary coronary intervention for acute myocardial infarction and subsequent transcoronary transplantation of autologous stem cells.
    Steinwender C; Hofmann R; Kypta A; Kammler J; Kerschner K; Grund M; Sihorsch K; Gabriel C; Leisch F
    Clin Cardiol; 2008 Aug; 31(8):356-9. PubMed ID: 18727076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New drug-eluting stents, optimizing technique, and the problem of drug-eluting stent restenosis.
    Vaina S; Ong AT; Serruys PW
    Minerva Cardioangiol; 2005 Oct; 53(5):341-60. PubMed ID: 16179880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.
    Yoshida T; Sakata K; Nitta Y; Taguchi T; Kaku B; Katsuda S; Shimojima M; Gamou T; Nakahashi T; Konno T; Kawashiri MA; Yamagishi M; Hayashi K
    Heart Vessels; 2016 May; 31(5):635-42. PubMed ID: 25758470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelial Recovery in Bare Metal Stents and Drug-Eluting Stents on a Single-Cell Level.
    Cornelissen A; Guo L; Fernandez R; Kelly MC; Janifer C; Kuntz S; Sakamoto A; Jinnouchi H; Sato Y; Paek KH; Kolodgie FD; Romero ME; Surve D; Virmani R; Finn AV
    Arterioscler Thromb Vasc Biol; 2021 Aug; 41(8):2277-2292. PubMed ID: 34162228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
    Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
    Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis.
    Nishihira K; Shibata Y; Ishikawa T; Nomura K; Nakama T; Mine D; Inoue Y; Ashikaga K; Kuriyama N; Matsuyama A; Imamura T; Asada Y; Kitamura K
    Circ J; 2010 Nov; 74(11):2329-33. PubMed ID: 20890050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levels of circulating CD34+/KDR+ cells do not predict coronary in-stent restenosis.
    Haine SE; Van Craenenbroeck EM; Hoymans VY; Miljoen HP; Vandendriessche TR; Claeys MJ; Frederix G; Conraads VM; Bosmans JM; Vrints CJ
    Can J Cardiol; 2014 Jan; 30(1):102-8. PubMed ID: 24365195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model.
    Frey D; Billinger M; Meier P; Beslac O; Grossenbacher R; Hänni B; Hess OM
    J Invasive Cardiol; 2008 Dec; 20(12):631-4. PubMed ID: 19057024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist).
    Gori T
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo.
    Diaz-Rodriguez S; Rasser C; Mesnier J; Chevallier P; Gallet R; Choqueux C; Even G; Sayah N; Chaubet F; Nicoletti A; Ghaleh B; Feldman LJ; Mantovani D; Caligiuri G
    Eur Heart J; 2021 May; 42(18):1760-1769. PubMed ID: 33580685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Late occlusive in-stent restenosis of a bare-metal stent presenting with ST-elevation anterior MI: is restenosis better than a late stent thrombosis?
    Trabattoni D; Bartorelli AL
    Int J Cardiol; 2009 Jun; 135(2):e65-7. PubMed ID: 18644635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immobilisation of an anti-platelet adhesion and anti-thrombotic drug (EP224283) on polydopamine coated vascular stent promoting anti-thrombogenic properties.
    Bricout N; Chai F; Sobocinski J; Hertault A; Laure W; Ung A; Woisel P; Lyskawa J; Blanchemain N
    Mater Sci Eng C Mater Biol Appl; 2020 Aug; 113():110967. PubMed ID: 32487386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesenchymal stem cell seeding promotes reendothelialization of the endovascular stent.
    Wu X; Wang G; Tang C; Zhang D; Li Z; Du D; Zhang Z
    J Biomed Mater Res A; 2011 Sep; 98(3):442-9. PubMed ID: 21661093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.